Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 8;114(4):648–655. doi: 10.14309/ajg.0000000000000140

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology

Open Access This article is licensed under a Creative Commons Attribution- NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://crealrvecommons.org/licenses/by-nc-nd/4.0/.

PMC Copyright notice

Figure 2. — Fecal markers of patients with possible and probable CVID. (a) Fecal calprotectin levels in patients with probable CVID (n = 96, white bar) and in patients with possible CVID (n = 25, black bar). (b) Fecal α1-antitrypsin levels in patients with probable CVID (n = 96, white bar) and in patients with possible CVID (n = 19, black bar). Upper limits of laboratory reference ranges are marked with a dotted line: for fecal calprotectin 100 μg/g and for fecal α1-antitrypsin 268 μg/g. Results are shown for each bar (a and b) as average ± SEM. For statistical comparison between patients with possible and probable CVID, Mann-Whitney U test was used. **P < 0.0001; *P < 0.05. CVID, common variable immunodeficiency.